" class="no-js "lang="en-US"> Respiratory Archives - Page 2 of 2 - Medtech Alert
Friday, March 31, 2023

Breaking News

Insmed Completes Enrollment of Adult Patients in Phase 3 ASPEN Study of Brensocatib in Bronchiectasis NEC Establishes Subsidiaries in Europe for Strengthening Global AI Drug Development Business Flare Therapeutics Further Strengthens Leadership Team with Key Executive Appointments and Promotions Sensorion Appoints Khalil Barrage as Interim Chairman of the Board Ablaze Pharmaceuticals Plans Development of Innovative GPC3 Targeted Radiopharmaceutical Therapy for Liver Cancer in Greater China Hansa Biopharma Completes Enrollment in Phase 2 Study of Imlifidase in Guillain-Barré Syndrome (GBS) ProJenX Announces Formation of Scientific Advisory Board for Development of ALS Treatment NADclinic Group, BioStarks and Do Not Age Announce Exclusive Partnership to Revolutionise Personalised Longevity PathAI Announces Collaboration with GSK on NASH Phase 2b Clinical Trial Nanoscope Therapeutics Announces Positive Topline Results from Phase 2b RESTORE Trial of MCO-010 for the Treatment of Retinitis Pigmentosa

Sort by:

Date

Top Post

Pfizer Announces Start of Phase 3 Clinical Trial in Adults for its Investigational Vaccine Against Respiratory Syncytial Virus (RSV) | Pharmtech Focus

Pfizer Announces Start of Phase 3 Clinical Trial in Adults for its Investigational Vaccine Against Respiratory Syncytial Virus (RSV)

Pfizer Inc. (NYSE:PFE) today announced the initiation of RENOIR (RSV vaccine Efficacy study iNOlder adults Immunized against RSV […]

Read more

Diseases

 NuvoAir Respiratory Platform Shows Promise for Long-Term Remote Monitoring of Asthma | Pharmtech Focus

NuvoAir Respiratory Platform Shows Promise for Long-Term Remote Monitoring of Asthma

Three new studies show how home monitoring technology – developed by leading digital health company NuvoAir – […]

Diseases

 Rising Demand for Needle-free Vaccines to Drive Innovation in the Respiratory Virus Vaccines Market | Pharmtech Focus

Rising Demand for Needle-free Vaccines to Drive Innovation in the Respiratory Virus Vaccines Market

A vaccination refers to a biological product that is utilized to provide acquired immunity against a […]

Diseases

 Tezepelumab Regulatory Submission Accepted and Granted FDA Priority Review in the US for the Treatment of Patients with Asthma | Pharmtech Focus

Tezepelumab Regulatory Submission Accepted and Granted FDA Priority Review in the US for the Treatment of Patients with Asthma

AstraZeneca’s Biologics License Application (BLA) for tezepelumab has been accepted and granted Priority Review for […]

Diseases

 NuvoAir Raises $12M in Series A Funding to Improve the Care of Millions Suffering From Lung Conditions | Pharmtech Focus

NuvoAir Raises $12M in Series A Funding to Improve the Care of Millions Suffering From Lung Conditions

NuvoAir – the digital health company on a mission to improve the lives of millions […]

Diseases

 Hephaï Files Software Patent for its Digital Education Platform Designed to Improve Patient Inhaler Use | Pharmtech Focus

Hephaï Files Software Patent for its Digital Education Platform Designed to Improve Patient Inhaler Use

Hephaï, a French start-up developing an AI-based digital education platform, today announces that it has […]

Diseases

 Amgen Announces Tezepelumab Biologics License Application Submitted To U.S. FDA | Pharmtech Focus

Amgen Tezepelumab BLA Submitted to U.S. FDA

Amgen (NASDAQ:AMGN) today announced its partner AstraZeneca (NASDAQ:AZN) submitted a Biologics License Application (BLA) to […]

Diseases

 Research Presented at RDD 2021 Suggests That Acoustic Technology Is a Viable Alternative to High-cost Electronic Smart Inhalers | Pharmtech Focus

Research Presented at RDD 2021 Suggests That Acoustic Technology Is a Viable Alternative to High-cost Electronic Smart Inhalers

Research presented at the Respiratory Drug Delivery (RDD) 2021 conference suggests that inhalers using acoustic […]

  1. Insmed Completes Enrollment of Adult Patients in Phase 3 ASPEN Study of Brensocatib in Bronchiectasis

    Clinical Trials

     Read more
  2. NEC Establishes Subsidiaries in Europe for Strengthening Global AI Drug Development Business

    Drug Development

     Read more
  3. Flare Therapeutics Further Strengthens Leadership Team with Key Executive Appointments and Promotions

    Appointments

     Read more
  4. Sensorion Appoints Khalil Barrage as Interim Chairman of the Board

    Appointments

     Read more
  5. Ablaze Pharmaceuticals Plans Development of Innovative GPC3 Targeted Radiopharmaceutical Therapy for Liver Cancer in Greater China

    Diseases

     Read more